Home › Trial NCT05781633
The Efficacy and Safety of Eutideron, Etoposide, and Bevacizumab in Patients With Brain Metastases From Breast Cancer.
- Trial IDNCT05781633
- StatusUnknown
- PhaseN/A
- Study typeInterventional
- SponsorTianjin Medical University Cancer Institute and Hospital
- Enrollment43
- Start date2022-07-20
- ConditionsMammary Neoplasms, Human
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.